TIDES Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

Wave Life Sciences at TIDES Europe 2026

Nov 3–5, 2026 Amsterdam, Netherlands ~900 attendees Website

Wave Life Sciences takes part in 2 sessions at TIDES Europe 2026 in Amsterdam. Its sessions cover oligonucleotide design and chemistry, with a focus on stereopure molecules. It discusses applying small-molecule drug design principles to improve the drug-like properties of siRNA, and making and characterizing stereopure chimeric oligonucleotides.

OrganizationTIDES Europe 2026 Attendance
Wave Life Sciences
Cambridge, Massachusetts
Biotech
Develops stereopure oligonucleotide medicines, including siRNA, antisense and RNA editing candidates.
Talk
Wed Nov 4
09:05–09:35
Applying Small Molecule Drug Design Principles to Improve the Drug-like Properties of siRNA
Designing siRNA the way chemists design small-molecule drugs, controlling each linkage to get lasting gene silencing in mouse liver and kidney.
Talk
Thu Nov 5
16:30–17:00
Synthesis and Characterization of Stereopure Chimeric Oligonucleotides
Making and testing oligonucleotides in which every backbone link has one fixed mirror-image form, in small batches, to link structure to activity.

Explore the full TIDES Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Amsterdam. Leave your work email and we’ll be in touch.

Privacy

Download the full TIDES Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Wave Life Sciences

Tell us what you sell and we’ll find the people at Wave Life Sciences most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by TIDES Europe or its organizers. Submit a correction